| 1 |
32626768 | Study on Genotyping Polymorphism and Sequencing of N-Acetyltransferase 2 (NAT2) among Al-Ahsa Population. | 2020 |
2 |
| 2 |
30047605 | The association between the NAT2 genetic polymorphisms and risk of DILI during anti-TB treatment: a systematic review and meta-analysis. | 2018 Dec |
2 |
| 3 |
27340556 | Development of a prediction system for anti-tuberculosis drug-induced liver injury in Japanese patients. | 2016 |
3 |
| 4 |
23190413 | Sex, ethnicity, and slow acetylator profile are the major causes of hepatotoxicity induced by antituberculosis drugs. | 2013 Feb |
1 |
| 5 |
19891553 | Genetic polymorphisms of drug-metabolizing enzymes and anti-TB drug-induced hepatitis. | 2009 Nov |
2 |
| 6 |
18023090 | NAT2 6A, a haplotype of the N-acetyltransferase 2 gene, is an important biomarker for risk of anti-tuberculosis drug-induced hepatotoxicity in Japanese patients with tuberculosis. | 2007 Dec 7 |
4 |
| 7 |
29788627 | NAT2 polymorphisms and their influence on the pharmacology and toxicity of isoniazid in TB patients. | 2007 May |
1 |